Navigation Links
Ischemic preconditioning for cerebral infarction: Is it related to upregulation of VEGF?
Date:7/23/2014

Neuroprotection by ischemic preconditioning has been confirmed by many studies, but the precise mechanism remains unclear. In a study released in the Neural Regeneration Research (Vol. 9, No. 11, 2014), Dr. Yong Liu and co-workers from Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, China performed cerebral ischemic preconditioning in rats by simulating a transient ischemic attack, and explored the mechanism underlying the neuroprotective effect of ischemic preconditioning. Researchers discovered that the infarct volume became significantly smaller underwent preconditioning. Furthermore, vascular endothelial growth factor immunoreactivity was considerably greater in the hippocampal CA3 region of preconditioned rats. Their results suggest that the protective effects of ischemic preconditioning on focal cerebral infarction are associated with upregulation of vascular endothelial growth factor.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. Molecular regulation of hypoxic-ischemic brain damage
2. 660 nm red light-enhanced BMSCs transplantation for hypoxic-ischemic brain damage
3. Imaging technology to improve survival of ischemic disease patients
4. Normobaric oxygen preconditioning for cerebral ischemic injury
5. Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after ACI
6. Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury
7. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
8. What increases the neuronal plasticity of endogenous NSCs after focal cerebral ischemia?
9. Neuropeptide Y protects cerebral cortical neurons
10. Babies born in Canada to immigrant mothers have lower risk of cerebral palsy: Study
11. Sex-specific changes in cerebral blood flow begin at puberty, Penn study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ischemic preconditioning for cerebral infarction: Is it related to upregulation of VEGF?
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... ... 29, 2016 , ... Summit for Stem Cell has received a $250,000 grant ... stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is ... Scripps Research Institute in San Diego, CA. , The aim of of ...
(Date:4/28/2016)... Hill, Conn. (PRWEB) , ... April 28, 2016 ... ... of financing and ongoing support for Connecticut's innovative, growing companies, today announced the ... digital health and financial technology (fintech) companies. , “VentureClash looks to ...
(Date:4/27/2016)... ... 2016 , ... Shimadzu Scientific Instruments (SSI) will be showcasing ... Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for ... stop by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC ...
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
Breaking Biology Technology: